Related Experiment Video
Updated: Aug 9, 2026
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Lipoprotein receptor activity of peritoneal macrophages from insulin-deficient mice
Abstract:
Binding, uptake and degradation of 125I-labeled normal very low density lipoprotein (125I-n-VLDL) from normal swine plasma and 125I-labeled beta-migrating VLDL (125I-beta-VLDL) from hypercholesterolemic rabbit plasma by peritoneal macrophages of mice rendered insulin-deficient by streptozotocin (250 mg/kg) were studied. It was found that the amount of binding, uptake and degradation of 125I-n-VLDL by macrophages from the diabetic mice was 2-fold or 2.5-fold higher than by macrophages from normal mice, resulting from an increase in the binding capacity of VLDL receptors on the macrophages from the insulin-deficient rodents. In contrast, the binding, uptake and degradation of 125I-beta-VLDL by macrophages from diabetic mice were reduced to only about 45% of normal levels because of a decrease in the number and affinity of the receptors for beta-VLDL. These experimental results indicate that n-VLDL is more important than beta-VLDL in the pathogenesis of atherosclerosis in insulin-dependent diabetes.
Insights
Insulin deficiency in mice increases normal very low-density lipoprotein (n-VLDL) uptake by macrophages, suggesting n-VLDL
Area of Science:
- Metabolic disorders
- Lipid metabolism
- Immunology
Background:
- Insulin deficiency, induced by streptozotocin, significantly alters lipoprotein metabolism.
- Macrophages play a crucial role in lipoprotein clearance and are implicated in atherosclerosis.
- Very low-density lipoprotein (VLDL) exists in different forms, including normal (n-VLDL) and beta-migrating (beta-VLDL), with distinct metabolic fates.
Purpose of the Study:
- To investigate the differential binding, uptake, and degradation of normal VLDL (n-VLDL) and beta-migrating VLDL (beta-VLDL) by macrophages in insulin-deficient mice.
- To elucidate the role of VLDL receptors in mediating these processes in the context of diabetes-induced metabolic changes.
Main Methods:
- Peritoneal macrophages were isolated from streptozotocin-induced insulin-deficient mice and normal control mice.
- The binding, uptake, and degradation of 125I-labeled normal swine VLDL (125I-n-VLDL) and 125I-labeled hypercholesterolemic rabbit beta-VLDL (125I-beta-VLDL) by these macrophages were quantified.
Main Results:
- Macrophages from diabetic mice showed a 2- to 2.5-fold increase in the binding, uptake, and degradation of 125I-n-VLDL compared to normal mice, attributed to increased VLDL receptor binding capacity.
- Conversely, the binding, uptake, and degradation of 125I-beta-VLDL were reduced to approximately 45% of normal levels in diabetic mice, due to decreased receptor number and affinity.
- These findings highlight distinct alterations in the handling of different VLDL subclasses in insulin deficiency.
Conclusions:
- Normal VLDL (n-VLDL) appears to play a more significant role than beta-VLDL in the pathogenesis of atherosclerosis in insulin-dependent diabetes.
- The differential regulation of VLDL receptor-mediated uptake of n-VLDL and beta-VLDL by macrophages in insulin deficiency has critical implications for understanding diabetic dyslipidemia and cardiovascular risk.
